• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中、大血管血管炎的细胞信号通路。

Cellular Signaling Pathways in Medium and Large Vessel Vasculitis.

机构信息

Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.

Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.

出版信息

Front Immunol. 2020 Sep 25;11:587089. doi: 10.3389/fimmu.2020.587089. eCollection 2020.

DOI:10.3389/fimmu.2020.587089
PMID:33072134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7544845/
Abstract

Autoimmune and autoinflammatory diseases of the medium and large arteries, including the aorta, cause life-threatening complications due to vessel wall destruction but also by wall remodeling, such as the formation of wall-penetrating microvessels and lumen-stenosing neointima. The two most frequent large vessel vasculitides, giant cell arteritis (GCA) and Takayasu arteritis (TAK), are HLA-associated diseases, strongly suggestive for a critical role of T cells and antigen recognition in disease pathogenesis. Recent studies have revealed a growing spectrum of effector functions through which T cells participate in the immunopathology of GCA and TAK; causing the disease-specific patterning of pathology and clinical outcome. Core pathogenic features of disease-relevant T cells rely on the interaction with endothelial cells, dendritic cells and macrophages and lead to vessel wall invasion, formation of tissue-damaging granulomatous infiltrates and induction of the name-giving multinucleated giant cells. Besides antigen, pathogenic T cells encounter danger signals in their immediate microenvironment that they translate into disease-relevant effector functions. Decisive signaling pathways, such as the AKT pathway, the NOTCH pathway, and the JAK/STAT pathway modify antigen-induced T cell activation and emerge as promising therapeutic targets to halt disease progression and, eventually, reset the immune system to reestablish the immune privilege of the arterial wall.

摘要

大中动脉的自身免疫和自身炎症性疾病,包括主动脉,由于血管壁破坏以及血管壁重塑(如穿透血管壁的微血管形成和管腔狭窄的新生内膜形成)而导致危及生命的并发症。两种最常见的大血管血管炎,巨细胞动脉炎(GCA)和 Takayasu 动脉炎(TAK),与 HLA 相关,强烈提示 T 细胞和抗原识别在疾病发病机制中起关键作用。最近的研究揭示了 T 细胞在 GCA 和 TAK 免疫病理学中参与的越来越多的效应功能;导致疾病特异性病理和临床结果的模式。与疾病相关的 T 细胞的核心致病特征依赖于与内皮细胞、树突状细胞和巨噬细胞的相互作用,导致血管壁浸润、形成组织损伤性肉芽肿浸润和诱导命名的多核巨细胞。除了抗原外,致病性 T 细胞在其局部微环境中还会遇到危险信号,将其转化为与疾病相关的效应功能。决定性的信号通路,如 AKT 通路、NOTCH 通路和 JAK/STAT 通路,改变抗原诱导的 T 细胞激活,并成为有希望的治疗靶点,以阻止疾病进展,并最终重置免疫系统,重新建立动脉壁的免疫特权。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7544845/80ce2976e5de/fimmu-11-587089-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7544845/e63beabcf531/fimmu-11-587089-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7544845/e414df8f7b20/fimmu-11-587089-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7544845/993c0cc6c5e3/fimmu-11-587089-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7544845/e69d18c9b11f/fimmu-11-587089-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7544845/78cf2e3cfb0a/fimmu-11-587089-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7544845/80ce2976e5de/fimmu-11-587089-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7544845/e63beabcf531/fimmu-11-587089-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7544845/e414df8f7b20/fimmu-11-587089-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7544845/993c0cc6c5e3/fimmu-11-587089-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7544845/e69d18c9b11f/fimmu-11-587089-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7544845/78cf2e3cfb0a/fimmu-11-587089-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5deb/7544845/80ce2976e5de/fimmu-11-587089-g006.jpg

相似文献

1
Cellular Signaling Pathways in Medium and Large Vessel Vasculitis.中、大血管血管炎的细胞信号通路。
Front Immunol. 2020 Sep 25;11:587089. doi: 10.3389/fimmu.2020.587089. eCollection 2020.
2
[Pathogenesis of large vessel vasculitides].[大血管血管炎的发病机制]
Z Rheumatol. 2020 Aug;79(6):505-515. doi: 10.1007/s00393-020-00809-z.
3
The Immunopathology of Giant Cell Arteritis Across Disease Spectra.巨细胞动脉炎疾病谱中的免疫病理学。
Front Immunol. 2021 Feb 25;12:623716. doi: 10.3389/fimmu.2021.623716. eCollection 2021.
4
Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis-Similarities and Differences.巨细胞动脉炎和 Takayasu 动脉炎的发病机制-相似与不同。
Curr Rheumatol Rep. 2020 Aug 26;22(10):68. doi: 10.1007/s11926-020-00948-x.
5
Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.JAK-STAT 信号抑制在大中血管血管炎中的致病性免疫反应。
Circulation. 2018 May 1;137(18):1934-1948. doi: 10.1161/CIRCULATIONAHA.117.030423. Epub 2017 Dec 18.
6
Innate and Adaptive Immunity in Giant Cell Arteritis.巨细胞动脉炎的固有免疫和适应性免疫。
Front Immunol. 2021 Feb 25;11:621098. doi: 10.3389/fimmu.2020.621098. eCollection 2020.
7
Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis.大血管血管炎外周免疫表型变化与临床特征的显著相关性。
Arthritis Res Ther. 2019 Dec 30;21(1):304. doi: 10.1186/s13075-019-2068-7.
8
Immune checkpoint dysfunction in large and medium vessel vasculitis.大中型血管炎中的免疫检查点功能障碍。
Am J Physiol Heart Circ Physiol. 2017 May 1;312(5):H1052-H1059. doi: 10.1152/ajpheart.00024.2017. Epub 2017 Mar 17.
9
[Pathogenesis of primary large vessel arteritis].[原发性大血管动脉炎的发病机制]
Rev Med Interne. 2009 Jul;30(7):578-84. doi: 10.1016/j.revmed.2008.08.002. Epub 2008 Sep 18.
10
MMP (Matrix Metalloprotease)-9-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis.MMP-9 产生的单核细胞使 T 细胞能够侵入血管壁并导致血管炎。
Circ Res. 2018 Aug 31;123(6):700-715. doi: 10.1161/CIRCRESAHA.118.313206.

引用本文的文献

1
Elevated soluble CD226 in Takayasu arteritis is useful for differentiation from giant cell arteritis, disease activity assessment, and prognosis prediction.Takayasu动脉炎中可溶性CD226升高有助于与巨细胞动脉炎相鉴别、疾病活动度评估及预后预测。
Medicine (Baltimore). 2025 Jun 20;104(25):e42844. doi: 10.1097/MD.0000000000042844.
2
Adolescent Takayasu's arteritis with hypertensive intracerebral hemorrhage: a case report and literature review.青少年高安动脉炎合并高血压性脑出血:一例报告及文献复习
Front Pediatr. 2024 Aug 16;12:1432362. doi: 10.3389/fped.2024.1432362. eCollection 2024.
3
Comprehensive Review on Bimolecular Fluorescence Complementation and Its Application in Deciphering Protein-Protein Interactions in Cell Signaling Pathways.

本文引用的文献

1
Comment on: Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.评论:托珠单抗治疗难治性大动脉炎的长期疗效和安全性:3期随机对照TAKT研究的最终结果
Rheumatology (Oxford). 2020 Sep 1;59(9):e46-e47. doi: 10.1093/rheumatology/keaa253.
2
Roles of cytotoxic lymphocytes and MIC/LILR families in pathophysiology of Takayasu arteritis.细胞毒性淋巴细胞和MIC/LILR家族在大动脉炎病理生理学中的作用。
Inflamm Regen. 2020 Jun 2;40:9. doi: 10.1186/s41232-020-00119-6. eCollection 2020.
3
Active Aortitis and Dissection in Giant Cell Arteritis While on Tocilizumab Monotherapy.
双分子荧光互补及其在破译细胞信号通路中蛋白质-蛋白质相互作用的应用的综合综述。
Biomolecules. 2024 Jul 17;14(7):859. doi: 10.3390/biom14070859.
4
Neuro-ophthalmic complications of immune checkpoint inhibitor therapy: Current status and future directions.免疫检查点抑制剂治疗的神经眼科并发症:现状与未来方向
Front Ophthalmol (Lausanne). 2022 Nov 18;2:1044904. doi: 10.3389/fopht.2022.1044904. eCollection 2022.
5
Ultrasound Examination of Common Carotid Adventitial Thickness Can Differentiate Takayasu Arteritis and Large Vessel Giant Cell Arteritis.超声检查颈总动脉外膜厚度可鉴别大动脉炎和大血管巨细胞动脉炎。
J Pers Med. 2024 Jun 12;14(6):627. doi: 10.3390/jpm14060627.
6
Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature.真实世界临床实践中 Janus 激酶抑制剂治疗复发性巨细胞动脉炎的疗效及文献复习。
Arthritis Res Ther. 2024 Jun 5;26(1):116. doi: 10.1186/s13075-024-03314-9.
7
The Contribution of Innate Immunity in Large-Vessel Vasculitis: Detangling New Pathomechanisms beyond the Onset of Vascular Inflammation.先天免疫在大血管血管炎中的作用:厘清血管炎症发作之外的新发病机制。
Cells. 2024 Feb 1;13(3):271. doi: 10.3390/cells13030271.
8
Changes in the molecular profiles of large-vessel vasculitis treated with biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors.生物靶向改善病情抗风湿药物和 Janus 激酶抑制剂治疗的巨细胞动脉炎患者的分子谱变化。
Front Immunol. 2023 May 1;14:1197342. doi: 10.3389/fimmu.2023.1197342. eCollection 2023.
9
Design and Characterization of Baricitinib Incorporated PLA 3D Printed Pills by Fused Deposition Modeling: An Oral Pill for Treating Alopecia Areata.通过熔融沉积建模设计和表征巴瑞替尼掺入的聚乳酸3D打印药丸:一种治疗斑秃的口服药丸。
Polymers (Basel). 2023 Apr 8;15(8):1825. doi: 10.3390/polym15081825.
10
CD8 Regulatory T Cell Deficiency in Elderly-Onset Rheumatoid Arthritis.老年起病类风湿关节炎中的CD8调节性T细胞缺陷
J Clin Med. 2023 Mar 17;12(6):2342. doi: 10.3390/jcm12062342.
使用托珠单抗单药治疗时巨细胞动脉炎中的活动性主动脉炎和夹层形成
J Clin Rheumatol. 2021 Dec 1;27(8S):S832-S833. doi: 10.1097/RHU.0000000000001423.
4
Leukocyte Immunoglobulin-Like Receptors (LILRs) on Human Neutrophils: Modulators of Infection and Immunity.人类中性粒细胞上的白细胞免疫球蛋白样受体 (LILR):感染和免疫的调节剂。
Front Immunol. 2020 May 13;11:857. doi: 10.3389/fimmu.2020.00857. eCollection 2020.
5
JAK inhibitors as promising agents for refractory Takayasu arteritis.JAK抑制剂有望成为治疗难治性大动脉炎的药物。
Ann Rheum Dis. 2022 Apr;81(4):e67. doi: 10.1136/annrheumdis-2020-217577. Epub 2020 Apr 27.
6
Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis.空腹血糖、胆固醇和甘油三酯水平与巨细胞动脉炎发展呈负相关。
Rheumatology (Oxford). 2020 Nov 1;59(11):3229-3236. doi: 10.1093/rheumatology/keaa080.
7
Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis.托法替布成功缓解一名合并溃疡性结肠炎的难治性大动脉炎患者的病情。
Ann Rheum Dis. 2020 Aug;79(8):1125-1126. doi: 10.1136/annrheumdis-2019-216606. Epub 2020 Mar 25.
8
Targeting JAK/STAT pathway in Takayasu's arteritis.靶向大动脉炎中的 JAK/STAT 通路。
Ann Rheum Dis. 2020 Jul;79(7):951-959. doi: 10.1136/annrheumdis-2019-216900. Epub 2020 Mar 25.
9
Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis.鉴定两种主要的自身抗原,它们负向调节 Takayasu 动脉炎中的血管内皮激活。
Nat Commun. 2020 Mar 9;11(1):1253. doi: 10.1038/s41467-020-15088-0.
10
Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease.炎致衰老:炎症在与年龄相关的心血管疾病中的作用。
Eur Heart J. 2020 Aug 14;41(31):2974-2982. doi: 10.1093/eurheartj/ehz961.